Latest Head and neck cancer Stories

Radiation Pain In Neck, Head, Neck Cancer Eased By Antidepressant

2012-10-30 12:33:09

An oral rinse of the antidepressant doxepin significantly eased pain associated with oral mucositis in patients receiving radiation therapy for cancers of the head and neck, a study led by Mayo Clinic found. The findings were presented at the American Society for Radiation Oncology annual meeting in Boston. MULTIMEDIA ALERT: A video interview with Dr. Miller is available for journalists to download on the Mayo Clinic News Network. "Oral mucositis or mouth sores is a painful and...

HPV Test Combination Better Than Viral DNA Test Alone

Combination HPV Tests Better Than Viral DNA Test Alone For Detecting Certain Cancers

2012-09-19 09:44:56

Connie K. Ho for redOrbit.com – Your Universe Online Two new studies published in the journal of the American Association for Cancer Research discovered that assessments of the human papillomavirus (HPV) that test for a single DNA biomarker alone are a weak indicator for determining the risk of HPV-driven head and neck cancers. On the other hand, the studies point to a combination of genetic markers that may provide a more robust test. Past research has found that HPV can lead to...

Oncolytics Biotech Inc. Provides Update on Phase III Study of REOLYSIN(R) in Head and Neck Cancers

2012-09-12 02:29:38

CALGARY, Sept. 12, 2012 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC, NASDAQ:ONCY) today provided an update on its Phase III trial of REOLYSIN in combination with carboplatin and paclitaxel for the treatment of head and neck cancers (REO 018). The Company has conducted an internal analysis of the blinded combined clinical data for all 80 patients enrolled in the first stage of the study. The study remains blinded at this time. At the time of...

People With Early-Stage Follicular Lymphoma Often Have Good Outcomes, Many Options

2012-08-22 12:19:10

A University of Rochester Medical Center study challenges treatment guidelines for early stage follicular lymphoma, concluding that six different therapies can bring a remission, particularly if the patient is carefully examined and staged at diagnosis. The research underlines the fact that when cancer strikes, modern patients and their oncologists across the United States are taking many diverse treatment paths when there is scant data to support one method over another. This study...

Oncolytics Biotech(R) Inc. Completes Patient Enrollment in U.K. Phase I Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide in Patients with Advanced Malignances

2012-08-16 02:24:20

CALGARY, Aug. 16, 2012 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) today announced that it has completed patient enrollment in its U.K. Phase I clinical trial using intravenously-administered REOLYSIN in combination with cyclophosphamide in patients with advanced malignancies (REO 012). "We are pleased to complete enrollment of this technical study examining cyclophosphamide's potential to modulate the immune system's response to REOLYSIN," said...

$2.5 million National Institutes of Health grant supports research at Helen F. Graham Cancer Center at Christiana Care

2012-08-13 06:24:57

WILMINGTON, Del., Aug. 13, 2012 /PRNewswire-USNewswire/ -- A research team at the Helen F. Graham Cancer Center at Christiana Care Health System and the Center for Translational Cancer Research performs a key role in a prestigious National Institutes of Health research project grant of $2.5 million to continue groundbreaking work into the creation of artificial salivary glands. (Logo: http://photos.prnewswire.com/prnh/20090407/DC95299LOGO) Robert Witt, M.D., chief of the...

2 Viruses Associated With Prostate Cancer

2012-08-01 10:34:07

High-risk human papilloma virus found with Epstein Barr virus Two common viruses known to be associated with human cancers are both present – and may even be collaborating with each other - in most male prostate cancers, a new study suggests. The research involved examination of 100 specimens of normal, malignant and benign prostate samples from Australian men. It revealed that both the human papilloma virus (HPV) and Epstein Barr virus (EBV) were present in more than half of the...

Radiation Control Technologies, Inc. Announces Exclusive License to Two Patents from the National Institutes of Health

2012-07-30 06:25:24

ROCKVILLE, Md., July 30, 2012 /PRNewswire/ -- Radiation Control Technologies, Inc. (RCTI), a private development stage biopharmaceutical company developing RCT1938, a novel radiosensitizer that sensitizes tumor cells to killing by radiation while protecting healthy cells from radiation damage by inhibiting the synthesis of the novel target protein CD47, announced today that it has been granted an exclusive license to two patents from the National Institutes of Health (NIH). The...

OncoSec Receives ISO 13485 Quality Management System Certification

2012-07-30 02:25:28

SAN DIEGO, July 30, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OMS ElectroOncology therapies to treat solid tumor cancers, announced it has received notified body certification to the International Organization for Standardization's (ISO) 13485 standard for the "design, development, manufacture, and distribution of electroporation devices." The certification confirms the company's Quality Management System (QMS) and that the...

Mount Sinai Researchers Present Outcomes of Robotic Surgery in Tobacco Users with Head and Neck Cancer at American Head and Neck Society Annual Meeting

2012-07-26 23:02:50

Predictors of disease severity in human papillomavirus-derived head and neck cancer, tobacco use, and the dramatic benefits of robotic surgery in people with head and neck cancer are among landmark research presented by Mount Sinai School of Medicine at the Eighth International Conference on Head and Neck Cancer. New York, NY (PRWEB) July 26, 2012 Predictors of disease severity in human papillomavirus-derived head and neck cancer, tobacco use, and the dramatic benefits of robotic surgery...